source
- Lyora Therapeutics launches to revive early-stage genetic eye disease programs from Editas and BiogenLyora Therapeutics announced its formation as a new genetic‑medicine company focused on eye diseases. The firm will take over several early‑stage programs that were previously in the pipelines of E…
- Cyclospora infections hit record high in 2026, Michigan officials suspect lettuce as sourceInfections caused by the parasite Cyclospora have surged to a record level in 2026, with more than 30 states reporting cases that now exceed the previous U.S. high of about 4,700 set in 2019. The…